Successful First Surgical Procedures with IMPLANET Jazz Lock Implant

IMPLANET, a medical technology company specializing in vertebral and knee-surgery implants, today announces the successful results of the first surgical procedures using the Jazz Lock.
 
Having obtained CE marking and 510(k) clearance, Jazz Lock has been used in select hospitals in France, Italy and the United States. Initial positive results in over 25 cases strengthen Implanet’s intention to carry out the wide-scale international launch of Jazz Lock by the end of the year.
 
The first component of an innovative range of band products designed for degenerative spine disorder surgery, Jazz Lock broadens the Jazz technological platform, allowing Implanet to expand its activity in a spine market estimated to be worth over $200 million worldwide¹. Implanet offers surgeons a new implant with an optimized and reproducible surgical technique. Based on the polyester band platform, Jazz Lock simplifies the surgical procedure by replacing the locking screw and connecting rod with an innovative locking system.
 
Doctor Vincent Cunin, Deputy Chief of Service in the Spine Surgery department at Hospices Civils de Lyon(HCL), said: “As a spine surgeon, I have been using band implants for the last four years to correct spine deformities, with excellent post-operative clinical results. Jazz Lock’s arrival as part of the Implanet band range is a major breakthrough. This new implant’s ease of use during the first surgical procedures in Lyon, as well as the very encouraging initial post-operative clinical results, validate our choice. We will now follow these patients to confirm the long-term results. In my opinion, Jazz Lock will quickly become an indispensable spine implant to surgeons across the globe.”
 
Ludovic Lastennet, CEO of Implanet, added: “As announced following the regulatory clearance, Jazz Lock is the first component of an innovative range of band products designed for degenerative spine disorders that will rapidly be launched in accordance with our business plan. The positive results obtained in the first surgical procedures illustrate this implant’s potential for patients and surgeons alike. Jazz Lock further expands the breadth of our product offering, with its launch is scheduled for upcoming major spine congresses: Eurospine in Berlin in early October and NASS in Boston (USA) in late October.”

References
¹Source: i-Data for 2010